Streetbeat News

Revenues

AXP

American Express (NYSE:AXP) has significantly outperformed the market over the past 15 years, with an annualized return of 15.01%. A $1000 investment in AXP 15 years ago would now be worth $8,333.64, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 5:31 pm

KVUE

Kenvue Inc. (NYSE:KVUE) is trading at $23.16 with a P/E ratio of 40.58, lower than the industry average of 53.71. This could indicate undervaluation or weak growth prospects. Investors should consider multiple metrics for a comprehensive analysis.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 5:15 pm

CERT

Certara (NASDAQ:CERT) has received mixed analyst ratings over the past three months, with a recent average price target of $17.5, down from $19.50. Analysts have adjusted their ratings and price targets in response to market conditions, reflecting a range of perspectives from bullish to bearish. Certara's financial performance shows a 3.17% revenue growth, a net margin of -13.48%, and a debt-to-equity ratio of 0.3.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 5:01 pm

PHR

Phreesia (NYSE:PHR) has received diverse analyst ratings over the past three months, with a mix of bullish and somewhat bullish sentiments. The average 12-month price target has slightly increased to $29.00. Analysts have adjusted their ratings and price targets, reflecting their responses to Phreesia's recent performance and market conditions. Phreesia has shown strong revenue growth and effective debt management, but faces challenges with net margin and asset utilization.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 5:01 pm

LXRX

Lexicon Pharmaceuticals (NASDAQ:LXRX) has received 7 analyst ratings in the past three months, all of which are bullish. The average 12-month price target is $10.00, with no changes in recent months. The company has shown significant revenue growth but faces challenges with negative net margins, ROE, and ROA, and a high debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 5:01 pm

SBUX

Starbucks (NASDAQ:SBUX) has delivered an average annual return of 11.11% over the past 20 years, outperforming the market by 2.7% annually. A $100 investment in Starbucks 20 years ago would now be worth $828.39, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 5:00 pm

NVO

Novo Nordisk (NYSE:NVO) has significantly outperformed the market over the past 5 years, with an annualized return of 36.66%. A $1000 investment in NVO 5 years ago would now be worth $4,660.74, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 5:00 pm

GGG

Graco (NYSE:GGG) has received mixed analyst ratings over the last quarter, with a recent average price target of $85.0, slightly down from $86.75. Analysts have adjusted their ratings and price targets, reflecting a cautious outlook. Graco's financials show strong profitability and efficient asset management, but recent revenue growth has been challenging.

Portfolio Pulse from Benzinga Insights

September 27, 2024 | 5:00 pm

VWAGY

Porsche SE has lowered its 2024 earnings forecast to a range of $2.4 billion to $4.4 billion, down from the previous estimate of $3.5 billion to $5.5 billion. This adjustment follows Volkswagen's revised sales and profit expectations for 2024.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 4:39 pm

F

GM

STLA

VWAGY

Volkswagen reports that the worsening macroeconomic environment is negatively impacting its business. This could have implications for the automotive industry, including companies like Ford, General Motors, Stellantis, and Volkswagen's US-listed ADRs.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2024 | 4:38 pm